Oncology & Cancer

A novel strategy to suppress triple negative breast cancer growth

In 2022, a team of researchers at Baylor College of Medicine discovered that a little-known enzyme called MAPK4 is involved in the growth of triple negative breast cancer (TNBC) and its resistance to certain therapies. Looking ...

Inflammatory disorders

Could bioprinted skin uncover a new treatment for eczema?

Mayo Clinic has developed its first 3D prototype of human skin bioprinted to model inflammatory skin disease. 3D bioprinting is a technology that mixes bioinks with living cells to print natural tissue-like structures in ...

Oncology & Cancer

Cellular 'fingerprint' may offer early warning of cancer risk

For nearly every disease, age is a major risk factor, and cancer is no exception. Between the ages of 25 and 65, an individual's risk of developing cancer skyrockets by 4,000%. A new study explores a "fingerprint" in cells ...

page 7 from 40